Bloom Syndrome
RecQ Helicases
Telangiectasis
Harmful Algal Bloom
DNA Helicases
Sister Chromatid Exchange
Adenosine Triphosphatases
Werner Syndrome
Dwarfism
Eutrophication
Phytoplankton
Exodeoxyribonucleases
Microcystis
DNA Topoisomerases, Type I
Recombination, Genetic
DNA Repair
DNA, Cruciform
Photosensitivity Disorders
Down Syndrome
Fanconi Anemia
Metabolic Syndrome X
Rad51 Recombinase
DNA Ligases
Microcystins
Mutation
Marine Toxins
Crossing Over, Genetic
Genomic Instability
Rothmund-Thomson Syndrome
Hydroxyurea
Dinoflagellida
DNA
Polynucleotide Ligases
Chromosomes, Human, Pair 15
Nephrotic Syndrome
Fibroblasts
Replication Protein A
Krukenberg Tumor
Sjogren's Syndrome
Lakes
Chromosome Aberrations
DNA-Binding Proteins
DNA Damage
Molecular Sequence Data
Ataxia Telangiectasia
Heterozygote
Phenotype
Chromosome Disorders
Turner Syndrome
Evolution of the RECQ family of helicases: A drosophila homolog, Dmblm, is similar to the human bloom syndrome gene. (1/188)
Several eukaryotic homologs of the Escherichia coli RecQ DNA helicase have been found. These include the human BLM gene, whose mutation results in Bloom syndrome, and the human WRN gene, whose mutation leads to Werner syndrome resembling premature aging. We cloned a Drosophila melanogaster homolog of the RECQ helicase family, Dmblm (Drosophila melanogaster Bloom), which encodes a putative 1487-amino-acid protein. Phylogenetic and dot plot analyses for the RECQ family, including 10 eukaryotic and 3 prokaryotic genes, indicate Dmblm is most closely related to the Homo sapiens BLM gene, suggesting functional similarity. Also, we found that Dmblm cDNA partially rescued the sensitivity to methyl methanesulfonate of Saccharomyces cerevisiae sgs1 mutant, demonstrating the presence of a functional similarity between Dmblm and SGS1. Our analyses identify four possible subfamilies in the RECQ family: (1) the BLM subgroup (H. sapiens Bloom, D. melanogaster Dmblm, and Caenorhabditis elegans T04A11.6); (2) the yeast RECQ subgroup (S. cerevisiae SGS1 and Schizosaccharomyces pombe rqh1/rad12); (3) the RECQL/Q1 subgroup (H. sapiens RECQL/Q1 and C. elegans K02F3.1); and (4) the WRN subgroup (H. sapiens Werner and C. elegans F18C5.2). This result may indicate that metazoans hold at least three RECQ genes, each of which may have a different function, and that multiple RECQ genes diverged with the generation of multicellular organisms. We propose that invertebrates such as nematodes and insects are useful as model systems of human genetic diseases. (+info)The DNA helicase activity of BLM is necessary for the correction of the genomic instability of bloom syndrome cells. (2/188)
Bloom syndrome (BS) is a rare autosomal recessive disorder characterized by growth deficiency, immunodeficiency, genomic instability, and the early development of cancers of many types. BLM, the protein encoded by BLM, the gene mutated in BS, is localized in nuclear foci and absent from BS cells. BLM encodes a DNA helicase, and proteins from three missense alleles lack displacement activity. BLM transfected into BS cells reduces the frequency of sister chromatid exchanges and restores BLM in the nucleus. Missense alleles fail to reduce the sister chromatid exchanges in transfected BS cells or restore the normal nuclear pattern. BLM complements a phenotype of a Saccharomyces cerevisiae sgs1 top3 strain, and the missense alleles do not. This work demonstrates the importance of the enzymatic activity of BLM for its function and nuclear localization pattern. (+info)Oligomeric ring structure of the Bloom's syndrome helicase. (3/188)
Bloom's syndrome is a recessive human genetic disorder associated with an elevated incidence of many types of cancer. The Bloom's syndrome gene product, BLM, belongs to the RecQ subfamily of DNA helicases and is required for the maintenance of genomic stability in human cells - in particular, the suppression of reciprocal exchanges between sister chromatids. We have investigated the quaternary structure of BLM using a combination of size-exclusion chromatography and electron microscopy with reference-free image processing. We found that BLM forms hexameric ring structures with an overall diameter of approximately 13 nm surrounding a central hole of approximately 3.5 nm diameter. A fourfold symmetric square form with approximately 11 nm sides and a hole of approximately 4 nm diameter was also detected, which might represent a distinct oligomeric species or a side view of the hexameric form. Chromatography studies indicated that the majority of enzymatically active BLM has an apparent molecular mass of > 700 kDa, which is consistent with an oligomeric structure for BLM. This provides the first structural analysis of an oligomeric ring helicase of eukaryotic cellular origin. These results have implications for the mechanism of action of BLM and suggest that other RecQ family helicases, including the WRN protein associated with Werner's syndrome, might also adopt ring structures. (+info)Transfection of BLM into cultured bloom syndrome cells reduces the sister-chromatid exchange rate toward normal. (4/188)
The gene BLM, mutated in Bloom syndrome (BS), encodes the nuclear protein BLM, which when absent, as it is from most BS cells, results in genomic instability. A manifestation of this instability is an excessive rate of sister-chromatid exchange (SCE). Here we describe the effects on this abnormal cellular phenotype of stable transfection of normal BLM cDNAs into two types of BS cells, SV40-transformed fibroblasts and Epstein-Barr virus (EBV)-transformed lymphoblastoid cells. Clones of BLM-transfected fibroblasts produced normal amounts of BLM by western blot analysis and displayed a normal nuclear localization of the protein by immunofluorescence microscopy. They had a mean of 24 SCEs/46 chromosomes, in contrast to the mean of 69 SCEs in controls transfected only with the vector. BLM-transfected fibroblast clones that expressed highest levels of the BLM protein had lowest levels of SCE. The lymphoblastoid cells transfected with BLM had SCE frequencies of 22 and 42 in two separate experiments in which two different selectable markers were used, in contrast to 57 and 58 in vector-transfected cells; in this type cell, however, the BLM protein was below the level detectable by western blot analysis. These experiments prove that BLM cDNA encodes a functional protein capable of restoring to or toward normal the uniquely characteristic high-SCE phenotype of BS cells. (+info)Expression of the BLM gene in human haematopoietic cells. (5/188)
Bloom's syndrome (BS) is a rare autosomal recessive disorder characterized by stunted growth, sun-sensitive erythema and immunodeficiency. Chromosomal abnormalities are often observed. Patients with BS are highly predisposed to cancers. The causative gene for BS has been identified as BLM. The former encodes a protein, which is a homologue of the RecQ DNA helicase family, a family which includes helicases such as Esherichia coli RecQ, yeast Sgs1, and human WRN. WRN is encoded by the gene that when mutated causes Werner's syndrome. The function of BLM in DNA replication and repair has not yet been determined, however. To understand the function of BLM in haematopoietic cells and the cause of immunodeficiency in BS, expression of the BLM gene in various human tissues and haematopoietic cell lines was analysed and the involvement of BLM in immunoglobulin rearrangement examined. In contrast to WRN, BLM was expressed strongly in the testis and thymus. B, T, myelomonocytic and megakaryocytic cell lines also expressed BLM. All of the examined sequences at the junction of the variable (V), diversity (D) and joining (J) regions of the immunoglobulin heavy-chain genes were in-frame, and N-region insertions were also present. The frequency of abnormal rearrangements of the T cell receptor was slightly elevated in the peripheral T cells of patients with BS compared with healthy individuals, whereas a higher frequency of abnormal rearrangements was observed in the cells of patients with ataxia-telangiectasia (A-T). In DND39 cell lines, the induction of sterile transcription, which is required for class switching of immunoglobulin heavy-chain constant genes, was correlated with the induction of the BLM gene. Taking into consideration all these results, BLM may not be directly involved in VDJ recombination, but is apparently involved in the maintenance of the stability of DNA. (+info)Requirement of yeast SGS1 and SRS2 genes for replication and transcription. (6/188)
The SGS1 gene of the yeast Saccharomyces cerevisiae encodes a DNA helicase with homology to the human Bloom's syndrome gene BLM and the Werner's syndrome gene WRN. The SRS2 gene of yeast also encodes a DNA helicase. Simultaneous deletion of SGS1 and SRS2 is lethal in yeast. Here, using a conditional mutation of SGS1, it is shown that DNA replication and RNA polymerase I transcription are drastically inhibited in the srs2Delta sgs1-ts strain at the restrictive temperature. Thus, SGS1 and SRS2 function in DNA replication and RNA polymerase I transcription. These functions may contribute to the various defects observed in Werner's and Bloom's syndromes. (+info)Posttranscriptional gene silencing in Neurospora by a RecQ DNA helicase. (7/188)
The phenomenon of posttranscriptional gene silencing (PTGS), which occurs when a transgene is introduced into a cell, is poorly understood. Here, the qde-3 gene, which is required for the activation and maintenance of gene silencing in the fungus Neurospora crassa, was isolated. Sequence analysis revealed that the qde-3 gene belongs to the RecQ DNA helicase family. The QDE3 protein may function in the DNA-DNA interaction between introduced transgenes or with an endogenous gene required for gene-silencing activation. In animals, genes that are homologous to RecQ protein, such as the human genes for Bloom's syndrome and Werner's syndrome, may also function in PTGS. (+info)A role for PML and the nuclear body in genomic stability. (8/188)
The PML gene of acute promyelocytic leukemia (APL) encodes a cell-growth and tumor suppressor. PML localizes to discrete nuclear bodies (NBs) that are disrupted in APL cells. The Bloom syndrome gene BLM encodes a RecQ DNA helicase, whose absence from the cell results in genomic instability epitomized by high levels of sister-chromatid exchange (SCE) and cancer predisposition. We show here that BLM co-localizes with PML to the NB. In cells from persons with Bloom syndrome the localization of PML is unperturbed, whereas in APL cells carrying the PML-RARalpha oncoprotein, both PML and BLM are delocalized from the NB into microspeckled nuclear regions. Treatment with retinoic acid (RA) induces the relocalization of both proteins to the NB. In primary PML-/- cells, BLM fails to accumulate in the NB. Strikingly, in PML-/- cells the frequency of SCEs is increased relative to PML+/+ cells. These data demonstrate that BLM is a constituent of the NB and that PML is required for its accumulation in these nuclear domains and for the normal function of BLM. Thus, our findings suggest a role for BLM in APL pathogenesis and implicate the PML NB in the maintenance of genomic stability. (+info)Bloom syndrome is a rare genetic disorder that affects approximately 1 in 100,000 individuals worldwide. It is caused by a mutation in the BLM gene, which codes for the Bloom syndrome protein (BLM). This protein plays a crucial role in the repair of DNA double-strand breaks and other types of genetic damage.
Characteristics:
Individuals with Bloom syndrome typically have short stature, small head size, and delicate features. They may also experience a range of health problems, including:
1. Increased risk of cancer: People with Bloom syndrome have an increased risk of developing various types of cancer, such as ovarian, breast, skin, and colon cancer.
2. Immune system problems: Individuals with Bloom syndrome may experience immune deficiency and autoimmune disorders, such as allergies and lupus.
3. Infertility: Many people with Bloom syndrome experience infertility or have difficulty conceiving.
4. Developmental delays: Children with Bloom syndrome may experience delayed development, including speech and language difficulties.
5. Skin changes: Individuals with Bloom syndrome may develop skin changes, such as thinning of the skin, easy bruising, and an increased risk of skin cancer.
6. Eye problems: Bloom syndrome can cause a range of eye problems, including cataracts, glaucoma, and detached retinas.
7. Increased risk of infections: People with Bloom syndrome may be more susceptible to infections due to their weakened immune system.
8. Other health problems: Individuals with Bloom syndrome may experience other health issues, such as hearing loss, kidney disease, and gastrointestinal problems.
Diagnosis:
Bloom syndrome can be diagnosed through a combination of clinical evaluation, family history, and genetic testing. Genetic testing can identify the presence of the BLM mutation that causes the disorder. Prenatal testing is also available for pregnant women who have a family history of Bloom syndrome.
Treatment:
There is no cure for Bloom syndrome, but treatment can help manage the symptoms and prevent complications. Treatment options may include:
1. Skin cancer screening and prevention: Regular skin exams can help detect skin cancer at an early stage, and preventive measures such as avoiding excessive sun exposure and using protective clothing and sunscreen can reduce the risk of skin cancer.
2. Eye care: Regular eye exams can help detect eye problems early, and prompt treatment can prevent vision loss.
3. Immune system support: Individuals with Bloom syndrome may be at increased risk of infections, so it's important to take steps to support the immune system, such as getting vaccinated against common illnesses and practicing good hygiene.
4. Developmental support: Children with Bloom syndrome may require extra support in school and at home to help them reach their full potential.
5. Managing other health problems: Depending on the specific health issues experienced by an individual with Bloom syndrome, treatment may involve medication, lifestyle changes, or other interventions to manage these conditions.
Prognosis:
The prognosis for individuals with Bloom syndrome varies depending on the specific health problems they experience. Some individuals may have a relatively mild course of the condition, while others may experience more severe health issues. With appropriate medical care and support, many individuals with Bloom syndrome can lead fulfilling lives. However, the condition can be associated with a shorter life expectancy compared to the general population.
Lifestyle Changes:
There are several lifestyle changes that can help manage the symptoms of Bloom syndrome and improve overall health. These may include:
1. Protecting the skin from the sun: Avoid excessive sun exposure, especially during peak hours, and use protective clothing and sunscreen to prevent skin damage.
2. Eating a healthy diet: A balanced diet that includes plenty of fruits, vegetables, whole grains, and lean protein can help support overall health.
3. Staying hydrated: Drinking plenty of water can help prevent dehydration, which can be a common issue for individuals with Bloom syndrome.
4. Avoiding smoking and excessive alcohol consumption: Both smoking and excessive alcohol consumption can worsen the symptoms of Bloom syndrome and increase the risk of certain health problems.
5. Getting regular exercise: Regular physical activity can help improve overall health and reduce the risk of certain health problems.
6. Managing stress: Stress can exacerbate the symptoms of Bloom syndrome, so it's important to find healthy ways to manage stress, such as through relaxation techniques or therapy.
7. Getting enough sleep: Adequate sleep is essential for overall health and well-being, and can help reduce the risk of certain health problems.
8. Avoiding exposure to toxins: Individuals with Bloom syndrome may be more susceptible to the effects of toxins, so it's important to avoid exposure to chemicals and other toxins whenever possible.
9. Keeping up-to-date on medical care: Regular check-ups with a healthcare provider can help identify any health issues early on and prevent complications.
Support Groups:
There are several support groups and organizations that provide information, resources, and support for individuals with Bloom syndrome and their families. These include:
1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome.
2. The Bloom Syndrome Foundation - A non-profit organization dedicated to supporting research and providing information and resources for individuals with Bloom syndrome and their families.
3. The Rare Disease United Foundation - Provides information and resources on rare diseases, including Bloom syndrome, as well as support for individuals and families affected by these conditions.
Online Resources:
There are several online resources available to help individuals with Bloom syndrome and their families learn more about the condition, connect with others, and find support. These include:
1. The National Organization for Rare Disorders (NORD) - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of healthcare providers and researchers.
2. The Bloom Syndrome Foundation - Offers information and resources on Bloom syndrome, as well as a registry for individuals with the condition to connect with others and receive updates on research and treatments.
3. Rare Disease United - Provides information and resources on rare diseases, including Bloom syndrome, as well as a directory of support groups and advocacy organizations.
4. The Global Bloom Syndrome Registry - A registry for individuals with Bloom syndrome to connect with others and receive updates on research and treatments.
5. The Bloom Syndrome Community - A Facebook group for individuals with Bloom syndrome and their families to connect, share information, and support one another.
These online resources can provide valuable information and support for individuals with Bloom syndrome and their families. It is important to note that while these resources can be helpful, they should not replace the advice of a qualified healthcare professional.
In the medical field, telangiectasis may be diagnosed through a physical examination and/or imaging tests such as ultrasound or MRI. Treatment options for telangiectasis depend on the underlying cause of the condition but may include topical creams or ointments, laser therapy, or lifestyle changes.
Some synonyms for telangiectasis are: spider veins, telangiectatic vessels, and spider naevi.
Note: Telangiectasis is not to be confused with telengectasis which is a condition where the blood vessels in the lung become dilated and can lead to pulmonary embolism.
Examples of syndromes include:
1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.
Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.
These conditions can cause significant physical discomfort, emotional distress, and social embarrassment. They can also lead to permanent scarring and disfigurement if left untreated or inadequately treated. Fortunately, there are many effective treatments available for facial dermatoses, ranging from topical creams and ointments to systemic medications and surgery.
Early diagnosis and appropriate treatment are essential for achieving the best possible outcomes for patients with facial dermatoses. A dermatologist can evaluate the patient's symptoms, perform a physical examination of the skin, and use diagnostic tests such as biopsies or blood tests to determine the underlying cause of the condition.
Once the diagnosis is established, the dermatologist will work with the patient to develop an individualized treatment plan that addresses their specific needs and concerns. This may involve a combination of self-care measures, medications, and other interventions. In some cases, a multidisciplinary approach involving other healthcare professionals such as plastic surgeons or psychologists may be necessary to provide comprehensive care.
In addition to treating the underlying condition, facial dermatoses can also have a significant impact on the patient's quality of life. Patients with these conditions may experience social stigma, anxiety, and depression, which can affect their relationships, work performance, and overall well-being. As such, it is essential for healthcare providers to address not only the physical symptoms but also the psychological and emotional needs of patients with facial dermatoses.
Overall, facial dermatoses are a common and diverse group of skin conditions that can have a significant impact on the patient's quality of life. Early diagnosis and appropriate treatment are essential for achieving the best possible outcomes, and a multidisciplinary approach is often necessary to provide comprehensive care.
People with Werner Syndrome typically have a normal intelligence and development during early childhood, but they experience a decline in physical and cognitive abilities as they age. They may also have an increased risk of developing certain cancers, such as lung and ovarian cancer. There is currently no cure for Werner Syndrome, and treatment is focused on managing the symptoms and preventing complications.
The primary diagnostic criteria for Werner Syndrome include:
1. Clinical manifestations of premature aging, such as wrinkled skin, graying hair, and short stature.
2. Normal intelligence and development during early childhood, followed by a decline in physical and cognitive abilities with age.
3. Presence of at least two of the following clinical features:
* Telangiectasias (spider veins)
* Ectropion (outward turning of the eyelids)
* Keratoconjunctivitis sicca (dry eyes)
* Poikilodermatous skin changes (skin thickening and pigmentation)
* Mucosal dryness and atrophy (thinning and drying of the mucous membranes)
4. Presence of a WRN gene mutation, confirmed by genetic testing.
The age of onset and severity of Werner Syndrome can vary widely among affected individuals, but most people experience symptoms within the first few years of life. The disorder is usually diagnosed in childhood or adolescence, based on clinical evaluation and genetic testing.
There is currently no cure for Werner Syndrome, and treatment is focused on managing the symptoms and preventing complications. This may include medication to manage dry eyes and skin, physical therapy to maintain joint mobility, and regular monitoring of the eyes and skin for early detection of any changes or problems. In some cases, surgery may be necessary to correct eye or skin problems.
Werner Syndrome is a rare disorder, and there is ongoing research into its causes and potential treatments. With proper management, many people with Werner Syndrome can lead active and fulfilling lives, despite the challenges posed by the disorder.
1. Medical Definition: In medicine, dwarfism is defined as a condition where an individual's height is significantly below the average range for their age and gender. The term "dwarfism" is often used interchangeably with "growth hormone deficiency," but the two conditions are not the same. Growth hormone deficiency is a specific cause of dwarfism, but there can be other causes as well, such as genetic mutations or chromosomal abnormalities.
2. Genetic Definition: From a genetic perspective, dwarfism can be defined as a condition caused by a genetic mutation or variation that results in short stature. There are many different genetic causes of dwarfism, including those caused by mutations in the growth hormone receptor gene, the insulin-like growth factor 1 (IGF1) gene, and other genes involved in growth and development.
3. Anthropological Definition: In anthropology, dwarfism is defined as a physical characteristic that is considered to be outside the normal range for a particular population or culture. This can include individuals who are short-statured due to various causes, including genetics, nutrition, or environmental factors.
4. Social Definition: From a social perspective, dwarfism can be defined as a condition that is perceived to be different or abnormal by society. Individuals with dwarfism may face social stigma, discrimination, and other forms of prejudice due to their physical appearance.
5. Legal Definition: In some jurisdictions, dwarfism may be defined as a disability or a medical condition that is protected by anti-discrimination laws. This can provide legal protections for individuals with dwarfism and ensure that they have access to the same rights and opportunities as others.
In summary, the definition of dwarfism can vary depending on the context in which it is used, and it may be defined differently by different disciplines and communities. It is important to recognize and respect the diversity of individuals with dwarfism and to provide support and accommodations as needed to ensure their well-being and inclusion in society.
Some examples of multiple abnormalities include:
1. Multiple chronic conditions: An individual may have multiple chronic conditions such as diabetes, hypertension, arthritis, and heart disease, which can affect their quality of life and increase their risk of complications.
2. Congenital anomalies: Some individuals may be born with multiple physical abnormalities or birth defects, such as heart defects, limb abnormalities, or facial deformities.
3. Mental health disorders: Individuals may experience multiple mental health disorders, such as depression, anxiety, and bipolar disorder, which can impact their cognitive functioning and daily life.
4. Neurological conditions: Some individuals may have multiple neurological conditions, such as epilepsy, Parkinson's disease, and stroke, which can affect their cognitive and physical functioning.
5. Genetic disorders: Individuals with genetic disorders, such as Down syndrome or Turner syndrome, may experience a range of physical and developmental abnormalities.
The term "multiple abnormalities" is often used in medical research and clinical practice to describe individuals who have complex health needs and require comprehensive care. It is important for healthcare providers to recognize and address the multiple needs of these individuals to improve their overall health outcomes.
There are several types of photosensitivity disorders, including:
1. Photodermatitis: This is a common condition that causes skin redness, itching, and blisters after exposure to UV radiation. It can be triggered by medications, certain plants, or even some cosmetics.
2. Solar urticaria: This condition causes hives and other skin symptoms after exposure to sunlight. The triggers can include not only UV radiation but also heat, wind, or cold.
3. Photosensitive epilepsy: This is a rare condition that can cause seizures in individuals who have a history of epilepsy. Exposure to certain types of light, especially flickering lights or bright colors, can trigger seizures.
4. Chronic actinic dermatitis: This condition causes skin inflammation and sensitivity to UV radiation, leading to redness, itching, and burning. It is more common in older adults and those with fair skin.
The symptoms of photosensitivity disorders can vary depending on the type of condition and the individual. Common symptoms include:
* Skin redness and irritation
* Itching and burning sensations
* Blisters or hives
* Swelling and inflammation
* Eye irritation or vision problems
* Headaches or fatigue
* Seizures (in the case of photosensitive epilepsy)
Photosensitivity disorders can be caused by a variety of factors, including:
1. Genetic predisposition: Some individuals may be more susceptible to photosensitivity due to their genetic makeup.
2. Medications: Certain medications, such as antibiotics and antipsychotics, can cause photosensitivity as a side effect.
3. Plants or other environmental factors: Exposure to certain plants or other environmental triggers can cause photosensitivity in some individuals.
4. Medical conditions: Certain medical conditions, such as lupus or porphyria, can increase the risk of developing photosensitivity.
There is no cure for photosensitivity disorders, but there are several treatment options available to help manage symptoms and prevent complications. These may include:
1. Avoiding triggers: Individuals with photosensitive conditions should avoid exposure to triggers such as sunlight or certain chemicals.
2. Protective clothing and gear: Wearing protective clothing and gear, such as hats and long sleeves, can help prevent skin exposure to UV radiation.
3. Medications: Topical creams and ointments, oral medications, or injectable treatments may be prescribed to manage symptoms such as itching and inflammation.
4. Phototherapy: Exposure to specific wavelengths of light, such as UVB or PUVA, can help improve skin conditions in some individuals.
5. Lifestyle modifications: Avoiding triggers, protecting the skin, and managing underlying medical conditions can help reduce the risk of complications associated with photosensitivity disorders.
It is important to note that photosensitivity disorders can be unpredictable, and the severity of symptoms can vary from person to person and over time. If you suspect you or someone you know may have a photosensitivity disorder, it is essential to consult with a healthcare professional for proper diagnosis and treatment.
Down syndrome can be diagnosed before birth through prenatal testing, such as chorionic villus sampling or amniocentesis, or after birth through a blood test. The symptoms of Down syndrome can vary from person to person, but common physical features include:
* A flat face with a short neck and small ears
* A short stature
* A wide, short hands with short fingers
* A small head
* Almond-shaped eyes that are slanted upward
* A single crease in the palm of the hand
People with Down syndrome may also have cognitive delays and intellectual disability, as well as increased risk of certain medical conditions such as heart defects, gastrointestinal problems, and hearing and vision loss.
There is no cure for Down syndrome, but early intervention and proper medical care can greatly improve the quality of life for individuals with the condition. Treatment may include speech and language therapy, occupational therapy, physical therapy, and special education programs. With appropriate support and resources, people with Down syndrome can lead fulfilling and productive lives.
There are currently no cures for Fanconi anemia, but bone marrow transplantation and other supportive therapies can help manage some of the symptoms and improve quality of life. Research into the genetics and molecular biology of Fanconi anemia is ongoing to better understand the disorder and develop new treatments.
Some of the common symptoms of Fanconi anemia include short stature, limb deformities, hearing loss, vision problems, and an increased risk of infections and cancer. Children with Fanconi anemia may also experience developmental delays, learning disabilities, and social and emotional challenges.
The diagnosis of Fanconi anemia is typically made based on a combination of clinical findings, laboratory tests, and genetic analysis. Treatment options for Fanconi anemia depend on the severity of the disorder and may include bone marrow transplantation, blood transfusions, antibiotics, and other supportive therapies.
Fanconi anemia is a rare disorder that affects approximately 1 in 160,000 births worldwide. It is more common in certain populations, such as Ashkenazi Jews and individuals of Spanish descent. Fanconi anemia can be inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene (one from each parent) to develop the disorder.
Overall, Fanconi anemia is a complex and rare genetic disorder that requires specialized medical care and ongoing research to better understand its causes and develop effective treatments. With appropriate management and supportive therapies, individuals with Fanconi anemia can lead fulfilling lives despite the challenges associated with the disorder.
1. Abdominal obesity (excess fat around the waistline)
2. High blood pressure (hypertension)
3. Elevated fasting glucose (high blood sugar)
4. High serum triglycerides (elevated levels of triglycerides in the blood)
5. Low HDL cholesterol (low levels of "good" cholesterol)
Having three or more of these conditions is considered a diagnosis of metabolic syndrome X. It is estimated that approximately 34% of adults in the United States have this syndrome, and it is more common in women than men. Risk factors for developing metabolic syndrome include obesity, lack of physical activity, poor diet, and a family history of type 2 diabetes or CVD.
The term "metabolic syndrome" was first introduced in the medical literature in the late 1980s, and since then, it has been the subject of extensive research. The exact causes of metabolic syndrome are not yet fully understood, but it is believed to be related to insulin resistance, inflammation, and changes in body fat distribution.
Treatment for metabolic syndrome typically involves lifestyle modifications such as weight loss, regular physical activity, and a healthy diet. Medications such as blood pressure-lowering drugs, cholesterol-lowering drugs, and anti-diabetic medications may also be prescribed if necessary. It is important to note that not everyone with metabolic syndrome will develop type 2 diabetes or CVD, but the risk is increased. Therefore, early detection and treatment are crucial in preventing these complications.
There are several types of genomic instability, including:
1. Chromosomal instability (CIN): This refers to changes in the number or structure of chromosomes, such as aneuploidy (having an abnormal number of chromosomes) or translocations (the movement of genetic material between chromosomes).
2. Point mutations: These are changes in a single base pair in the DNA sequence.
3. Insertions and deletions: These are changes in the number of base pairs in the DNA sequence, resulting in the insertion or deletion of one or more base pairs.
4. Genomic rearrangements: These are changes in the structure of the genome, such as chromosomal breaks and reunions, or the movement of genetic material between chromosomes.
Genomic instability can arise from a variety of sources, including environmental factors, errors during DNA replication and repair, and genetic mutations. It is often associated with cancer, as cancer cells have high levels of genomic instability, which can lead to the development of resistance to chemotherapy and radiation therapy.
Research into genomic instability has led to a greater understanding of the mechanisms underlying cancer and other diseases, and has also spurred the development of new therapeutic strategies, such as targeted therapies and immunotherapies.
In summary, genomic instability is a key feature of cancer cells and is associated with various diseases, including cancer, neurodegenerative disorders, and aging. It can arise from a variety of sources and is the subject of ongoing research in the field of molecular biology.
The main clinical features of Rothmund-Thomson Syndrome include:
1. Congenital anomalies: Individuals with RTS are born with a variety of physical abnormalities such as short stature, microcephaly (small head), and facial dysmorphism (abnormal facial features).
2. Skin abnormalities: The skin is thin, delicate, and susceptible to infections, blistering, and scarring. Individuals with RTS may develop poikiloderma (a condition characterized by irregularly pigmented patches on the skin).
3. Skeletal abnormalities: RTS can cause a range of skeletal defects such as short or missing limbs, joint deformities, and spinal abnormalities.
4. Craniofacial abnormalities: The syndrome can also result in craniofacial abnormalities such as micrognathia (small jaw), protruding eyes, and hearing loss.
5. Developmental delays: Individuals with RTS often experience developmental delays and intellectual disability. They may have difficulty with speech, language, and social interactions.
6. Increased risk of cancer: People with Rothmund-Thomson Syndrome have an increased risk of developing certain types of cancer, particularly osteosarcoma (bone cancer) and rhabdomyosarcoma (soft tissue cancer).
7. Autoimmune disorders: RTS can also lead to autoimmune disorders such as thyroiditis (inflammation of the thyroid gland) and vitiligo (loss of skin pigmentation).
8. Poor immune function: The syndrome can cause poor immune function, making individuals more susceptible to infections and less able to fight them off effectively.
9. Neurological problems: RTS can result in neurological issues such as seizures, tremors, and loss of coordination.
10. Short stature: Adults with Rothmund-Thomson Syndrome often have short stature and may experience delayed or arrested growth.
It's important to note that not all individuals with RTS will experience all of these symptoms, and the severity of the syndrome can vary widely from person to person. Treatment for Rothmund-Thomson Syndrome typically involves a multidisciplinary approach, including medical management, surgical interventions, and supportive care to address the various physical and developmental challenges associated with the condition.
The tumor is named after Friedrich Krukenberg, a German pathologist who first described it in 1890. It is also known as Krukenberg's tumor or omental tubercle.
Krukenberg tumors are typically small, ranging in size from a few millimeters to several centimeters, and they can be either benign (non-cancerous) or malignant (cancerous). They are often found in the upper part of the omentum, near the diaphragm.
The symptoms of Krukenberg tumor can include abdominal pain, bloating, and weight loss. If the tumor is malignant, it can spread to other parts of the body, such as the lymph nodes or liver.
Krukenberg tumors are rare and account for only about 1% to 2% of all gastrointestinal tumors. They are more common in women than men, and they often affect women in their reproductive years. The exact cause of Krukenberg tumors is not known, but they may be associated with pelvic inflammatory disease or endometriosis.
Treatment for Krukenberg tumor usually involves surgery to remove the tumor and any affected tissue. In some cases, chemotherapy or radiation therapy may also be recommended to kill any remaining cancer cells. The prognosis for Krukenberg tumors is generally good if the tumor is diagnosed and treated early. However, if the tumor is malignant and has spread to other parts of the body, the prognosis can be poorer.
Sjögren's syndrome can affect people of all ages, but it most commonly occurs in women between the ages of 40 and 60. The exact cause of the disorder is not known, but it is believed to be an autoimmune response, meaning that the immune system mistakenly attacks the glands as if they were foreign substances.
Symptoms of Sjögren's syndrome can vary in severity and may include:
* Dry mouth (xerostomia)
* Dry eyes (dry eye syndrome)
* Fatigue
* Joint pain
* Swollen lymph nodes
* Rash
* Sores on the skin
* Numbness or tingling in the hands and feet
* Sexual dysfunction
There is no cure for Sjögren's syndrome, but various treatments can help manage the symptoms. These may include:
* Medications to stimulate saliva production
* Eye drops to moisturize the eyes
* Mouthwashes to stimulate saliva production
* Pain relief medication for joint pain
* Anti-inflammatory medication to reduce swelling
* Immunosuppressive medication to suppress the immune system
* Hormone replacement therapy (HRT) to treat hormonal imbalances.
Sjögren's syndrome can also increase the risk of developing other autoimmune disorders, such as rheumatoid arthritis or lupus. It is important for people with Sjögren's syndrome to work closely with their healthcare provider to manage their symptoms and monitor their condition over time.
There are several types of chromosome aberrations, including:
1. Chromosomal deletions: Loss of a portion of a chromosome.
2. Chromosomal duplications: Extra copies of a chromosome or a portion of a chromosome.
3. Chromosomal translocations: A change in the position of a chromosome or a portion of a chromosome.
4. Chromosomal inversions: A reversal of a segment of a chromosome.
5. Chromosomal amplifications: An increase in the number of copies of a particular chromosome or gene.
Chromosome aberrations can be detected through various techniques, such as karyotyping, fluorescence in situ hybridization (FISH), or array comparative genomic hybridization (aCGH). These tests can help identify changes in the chromosomal makeup of cells and provide information about the underlying genetic causes of disease.
Chromosome aberrations are associated with a wide range of diseases, including:
1. Cancer: Chromosome abnormalities are common in cancer cells and can contribute to the development and progression of cancer.
2. Birth defects: Many birth defects are caused by chromosome abnormalities, such as Down syndrome (trisomy 21), which is caused by an extra copy of chromosome 21.
3. Neurological disorders: Chromosome aberrations have been linked to various neurological disorders, including autism and intellectual disability.
4. Immunodeficiency diseases: Some immunodeficiency diseases, such as X-linked severe combined immunodeficiency (SCID), are caused by chromosome abnormalities.
5. Infectious diseases: Chromosome aberrations can increase the risk of infection with certain viruses, such as human immunodeficiency virus (HIV).
6. Ageing: Chromosome aberrations have been linked to the ageing process and may contribute to the development of age-related diseases.
7. Radiation exposure: Exposure to radiation can cause chromosome abnormalities, which can increase the risk of cancer and other diseases.
8. Genetic disorders: Many genetic disorders are caused by chromosome aberrations, such as Turner syndrome (45,X), which is caused by a missing X chromosome.
9. Rare diseases: Chromosome aberrations can cause rare diseases, such as Klinefelter syndrome (47,XXY), which is caused by an extra copy of the X chromosome.
10. Infertility: Chromosome abnormalities can contribute to infertility in both men and women.
Understanding the causes and consequences of chromosome aberrations is important for developing effective treatments and improving human health.
The hallmark symptoms of AT are:
1. Ataxia: difficulty with coordination, balance, and gait.
2. Telangiectasias: small, red blood vessels visible on the skin, particularly on the face, neck, and arms.
3. Ocular telangiectasias: small, red blood vessels visible in the eyes.
4. Cognitive decline: difficulty with memory, learning, and concentration.
5. Seizures: episodes of abnormal electrical activity in the brain.
6. Increased risk of cancer: particularly lymphoma, myeloid leukemia, and breast cancer.
The exact cause of AT is not yet fully understood, but it is thought to be due to mutations in the ATM gene, which is involved in DNA damage response and repair. There is currently no cure for AT, but various treatments are available to manage its symptoms and prevent complications. These may include:
1. Physical therapy: to improve coordination and balance.
2. Occupational therapy: to assist with daily activities and fine motor skills.
3. Speech therapy: to improve communication and swallowing difficulties.
4. Medications: to control seizures, tremors, and other symptoms.
5. Cancer screening: regular monitoring for the development of cancer.
AT is a rare disorder, and it is estimated that only about 1 in 40,000 to 1 in 100,000 individuals are affected worldwide. It is important for healthcare providers to be aware of AT and its symptoms, as early diagnosis and intervention can improve outcomes for patients with this condition.
There are many different types of chromosome disorders, including:
1. Trisomy: This is a condition in which there is an extra copy of a chromosome. For example, Down syndrome is caused by an extra copy of chromosome 21.
2. Monosomy: This is a condition in which there is a missing copy of a chromosome.
3. Turner syndrome: This is a condition in which there is only one X chromosome instead of two.
4. Klinefelter syndrome: This is a condition in which there are three X chromosomes instead of the typical two.
5. Chromosomal translocations: These are abnormalities in which a piece of one chromosome breaks off and attaches to another chromosome.
6. Inversions: These are abnormalities in which a segment of a chromosome is reversed end-to-end.
7. Deletions: These are abnormalities in which a portion of a chromosome is missing.
8. Duplications: These are abnormalities in which there is an extra copy of a segment of a chromosome.
Chromosome disorders can have a wide range of effects on the body, depending on the type and severity of the condition. Some common features of chromosome disorders include developmental delays, intellectual disability, growth problems, and physical abnormalities such as heart defects or facial anomalies.
There is no cure for chromosome disorders, but treatment and support are available to help manage the symptoms and improve the quality of life for individuals with these conditions. Treatment may include medications, therapies, and surgery, as well as support and resources for families and caregivers.
Preventive measures for chromosome disorders are not currently available, but research is ongoing to understand the causes of these conditions and to develop new treatments and interventions. Early detection and diagnosis can help identify chromosome disorders and provide appropriate support and resources for individuals and families.
In conclusion, chromosome disorders are a group of genetic conditions that affect the structure or number of chromosomes in an individual's cells. These conditions can have a wide range of effects on the body, and there is no cure, but treatment and support are available to help manage symptoms and improve quality of life. Early detection and diagnosis are important for identifying chromosome disorders and providing appropriate support and resources for individuals and families.
Turner syndrome occurs in approximately 1 in every 2,500 to 3,000 live female births and is more common in girls born to older mothers. The symptoms of Turner syndrome can vary widely and may include:
* Short stature and delayed growth and development
* Infertility or lack of menstruation (amenorrhea)
* Heart defects, such as a narrowed aorta or a hole in the heart
* Eye problems, such as cataracts, glaucoma, or crossed eyes
* Hearing loss or deafness
* Bone and joint problems, such as scoliosis or clubfoot
* Cognitive impairments, including learning disabilities and memory problems
* Delayed speech and language development
* Poor immune function, leading to recurrent infections
Turner syndrome is usually diagnosed at birth or during childhood, based on physical characteristics such as short stature, low muscle tone, or heart defects. Chromosomal analysis can also confirm the diagnosis.
There is no cure for Turner syndrome, but treatment can help manage the symptoms and improve quality of life. Hormone replacement therapy may be used to stimulate growth and development in children, while adults with the condition may require ongoing hormone therapy to maintain bone density and prevent osteoporosis. Surgery may be necessary to correct heart defects or other physical abnormalities. Speech and language therapy can help improve communication skills, and cognitive training may be beneficial for learning disabilities.
The long-term outlook for individuals with Turner syndrome varies depending on the severity of the condition and the presence of any additional health problems. With proper medical care and support, many women with Turner syndrome can lead fulfilling lives, but they may face unique challenges related to fertility, heart health, and other issues.
Bloom syndrome
Bloom syndrome protein
Cancer
DNA repair
Genome instability
Progeroid syndromes
Cancer syndrome
Carcinogenesis
DNA repair-deficiency disorder
Mosaic (genetics)
RecQ helicase
RECQL4
RMI1
TOP3A
Flap structure-specific endonuclease 1
Aging-associated diseases
FANCF
FANCM
FANCE
Werner syndrome helicase
Fanconi anemia
Mutation
Human reproductive system
Actinic keratosis
Howard Bloom
FANCL
Crossover junction endodeoxyribonuclease
Telangiectasia
Sister chromatid exchange
Arginine finger
Obstetric ultrasonography
Psychology of religion
Childbirth
Billie Eilish
COVID-19 pandemic in Europe
Timeline of the COVID-19 pandemic in the United Kingdom (July-December 2021)
Kyoto (Phoebe Bridgers song)
Duke Thomas (character)
Zinc deficiency
Trevi Fountain
Rafael Martin
Oxycodone
Will Graham (character)
John Fahey (musician)
Brain
For the World Is Hollow and I Have Touched the Sky
Rina Sawayama
DNA damage theory of aging
Alien hand syndrome
Telomerase
Evil Queen
Telomeric repeat-binding factor 2
Ryuho Okawa
Per- and polyfluoroalkyl substances
Jasione montana
Norepinephrine transporter
Calcineurin
Paralytic shellfish poisoning
Breast cancer classification
Bloom syndrome: MedlinePlus Genetics
Bloom Syndrome - PubMed
Bloom Syndrome - GeneReviews® - NCBI Bookshelf
Bloom Syndrome - Norton & Elaine Sarnoff Center for Jewish Genetics
NIH VideoCast - Genomic Instability and Cancer: Insights from Analysis of Bloom Syndrome
Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein | eLife
Bloom syndrome patients and mice display accelerated epigenetic aging. | Aging Cell;: e13964, 2023 Aug 18. | MEDLINE | BVS...
DNA ligase - wikidoc
Orphanet: Search simple
Acanthosis Nigricans: Background, Pathophysiology, Etiology
Coriell Institute for Medical Research
Cancer: MedlinePlus
Research - 23andMe
Helicases and Genomic Integrity Section | National Institute on Aging
Leukemia | CancerQuest
Volume 18, Number 12, décembre 2002 - M/S : médecine sciences - Érudit
Biomarkers Search
In Big Shift, FDA Plans To Let 23andMe Market Genetic Tests To Consumers
NIH Guide: GENE THERAPY IN AGING
Publication Detail
Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses - United States, 2017-2019 |...
Conjunctival Telangiectasia - EyeWiki
The Most Common Genetic Disorders - ActiveBeat - Your Daily Dose of Health Headlines
Childhood Cancer Epidemiology: Overview, Tools of Study, Cancer Incidence
DeCS
2023 ICD-10-CM Diagnosis Code N20.0: Calculus of kidney
WHO EMRO | Seroprevalence of rubella among pregnant women in Khartoum state, Sudan | Volume 19, numéro 9 | La Revue de Santé de...
Education and Foster Care of Children Infected with HTLV-III/LAV
Causing Bloom's syndrome1
- 20. Point mutations causing Bloom's syndrome abolish ATPase and DNA helicase activities of the BLM protein. (nih.gov)
Bloom's15
- 3. [Function of RecQ family helicases and Bloom's syndrome]. (nih.gov)
- 6. Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase. (nih.gov)
- 7. Functions of RecQ family helicases: possible involvement of Bloom's and Werner's syndrome gene products in guarding genome integrity during DNA replication. (nih.gov)
- 9. The Bloom's syndrome helicase: keeping cancer at bay. (nih.gov)
- 11. Bloom's syndrome. (nih.gov)
- 12. The Bloom's syndrome gene product promotes branch migration of holliday junctions. (nih.gov)
- 13. Novel pro- and anti-recombination activities of the Bloom's syndrome helicase. (nih.gov)
- 15. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. (nih.gov)
- 16. Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. (nih.gov)
- 17. The Bloom's syndrome helicase can promote the regression of a model replication fork. (nih.gov)
- 19. Bloom's syndrome protein response to ultraviolet-C radiation and hydroxyurea-mediated DNA synthesis inhibition. (nih.gov)
- The team also observed protein-protein interaction between RUNX proteins and BLM - a protein that is impaired in the genetic disorder Bloom's syndrome - during the process of DNA repair. (genengnews.com)
- A defining feature of Bloom's syndrome is an elevated frequency of sister chromatide exchanges. (biomedcentral.com)
- Mutations of the BLM gene can result in Bloom's Syndrome, an autosomal recessive disorder, which leads to cancer predisposition. (nih.gov)
- Moreover, these compounds demonstrated cellular activity by inducing sister chromatid exchanges, a hallmark of Bloom's Syndrome, and via selective inhibition of cell proliferation of BLM+ cells over BLM- cells. (nih.gov)
Helicase8
- BLM (Bloom syndrome protein) is a RECQ-family helicase involved in the dissolution of complex DNA structures and repair intermediates. (elifesciences.org)
- The DNA Helicase Section was the first to discover a small molecule inhibitor of the WRN helicase, defective in the premature aging disease Werner syndrome. (nih.gov)
- Aggarwal M, Sommers JA, Shoemaker RH, Brosh RM Jr., Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress. (nih.gov)
- 2. Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells. (nih.gov)
- 18. Telomere and ribosomal DNA repeats are chromosomal targets of the bloom syndrome DNA helicase. (nih.gov)
- Bloom helicase (BLM) and its orthologs are essential for the maintenance of genome integrity. (nih.gov)
- The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase. (bvsalud.org)
- BLM, the helicase mutated in Bloom syndrome, is found in protein complexes together with topoisomerase IIIa (TOP3A) and a newly identified member, the RECQ-mediated genome instabilitity 1 (RMI1) protein, that process double Holliday junction intermediates into non-crossover recombinants [ 2 - 5 ]. (biomedcentral.com)
Myelodysplastic2
- In order to test this hypothesis we analysed in this study polymorphisms in the RMI1 , TOP3A and BLM , and their association with cancer risk in available case-control materials, namely AML/MDSs (acute myeloid leukemia and myelodysplastic syndromes), malignant melanoma, and bladder and breast cancer. (biomedcentral.com)
- The difference between the sexes is likely due to the more common occurrence of antecedent hematologic disorders such as myelodysplastic syndrome (MDS) in men because advanced MDS and similar disorders frequently evolve into AML. (medscape.com)
Genomic Instability and Cancer1
- 5. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. (nih.gov)
Autosomal recessive disorder1
- Bloom syndrome (BSyn) is an autosomal recessive disorder caused by variants in the BLM gene , which is involved in genome stability . (bvsalud.org)
Insulin-resistance4
- Bloom syndrome (BSyn) is characterized by severe pre- and postnatal growth deficiency, immune abnormalities, sensitivity to sunlight, insulin resistance, and a high risk for many cancers that occur at an early age. (nih.gov)
- These have been subdivided into insulin-resistance syndromes and fibroblast growth factor defects. (medscape.com)
- Insulin-resistance syndromes include those with mutations in the insulin receptors (ie, leprechaunism, Rabson-Mendenhall syndrome), peroxisome proliferator-activated receptor gamma (ie, type 1 diabetes with acanthosis nigricans and hypertension), 1-acylglycerol-3-phosphate O-acyl transferase-2 or seipin (Berardinelli-Seip syndrome), lamin A/C (Dunnigan syndrome), and Alstrom syndrome gene. (medscape.com)
- Evidence from cell studies indicates that persistent organic pollutants (POP) can induce insulin resistance, an essential component of the metabolic syndrome (MetS). (mdpi.com)
Mutations7
- Mutations in the BLM gene cause Bloom syndrome. (medlineplus.gov)
- Mutations altering BLM function are associated with highly elevated cancer susceptibility (Bloom syndrome). (biomedcentral.com)
- Klippel-Trenaunay syndrome can be caused by mutations in the PIK3CA gene. (nih.gov)
- The PIK3CA gene mutations associated with Klippel-Trenaunay syndrome alter the p110α protein. (nih.gov)
- Klippel-Trenaunay syndrome is one of several overgrowth syndromes, including megalencephaly-capillary malformation syndrome , that are caused by mutations in the PIK3CA gene. (nih.gov)
- Because not everyone with Klippel-Trenaunay syndrome has a mutation in the PIK3CA gene, it is possible that mutations in unidentified genes may also cause this condition. (nih.gov)
- Previously, we reported the emergence and spread of mutant Middle East respiratory syndrome coronavirus bearing spike mutations (I529T or D510G) with reduced affinity to human receptor CD26 during the outbreak. (cdc.gov)
Congenital2
- Noonan Syndrome is a fairly common autosomal dominant congenital disorder that occurs when one of four chromosomes is affected. (activebeat.com)
- Other hematologic disorders, such as myelofibrosis and aplastic anemia, and congenital disorders, such as Bloom syndrome and Down syndrome, also increase AML risk. (medscape.com)
Short stature4
- Bloom syndrome is an inherited disorder characterized by short stature, a skin rash that develops after exposure to the sun, and a greatly increased risk of cancer. (medlineplus.gov)
- Bloom syndrome is an inherited genetic disorder that causes short stature, skin rash and an increased risk of cancer. (jewishgenetics.org)
- 1, 2] Silver-Russell syndrome is characterized by intrauterine and postnatal growth retardation leading to a small-for-gestational-age (SGA) infant at birth, feeding difficulties during infancy, short stature, body asymmetry, characteristic triangular facies with prominent forehead, and several other anomalies. (medscape.com)
- The announcement came in a release late Thursday from the regulator that said it's authorizing 23andMe to market a specific test to consumers for Bloom Syndrome, a rare inherited disorder associated with short stature and various cancers that often result in death by the mid-20s. (forbes.com)
Genetic disorder1
- BLM defects represent the underlying cause of Bloom Syndrome, a rare genetic disorder that is marked by strong cancer predisposition. (nih.gov)
Disorder4
- Bloom syndrome is a rare disorder. (medlineplus.gov)
- Tourette syndrome (TS) is a common, chronic neuropsychiatric disorder characterized by the presence of fluctuating motor and phonic tics. (jneurosci.org)
- Although many of the descriptions about the disorder, which now bears his name [Tourette syndrome (TS)], have been revised, his belief that tics are a neurological movement disorder and not a psychiatric condition persists to the present ( Goetz and Klawans, 1982 ). (jneurosci.org)
- Klippel-Trenaunay syndrome is almost always sporadic, which means that it occurs in people with no history of the disorder in their family. (nih.gov)
20192
Chromosomal1
- Down Syndrome, a common chromosomal abnormality that effects approximately 1 in 1000 newborns (particularly in older expectant mothers), results when an extra copy of genes occurs on chromosome 21. (activebeat.com)
Telangiectasia1
- A Case of Bloom Syndrome with Conjunctival Telangiectasia. (aao.org)
Inheritance1
- Bloom syndrome exhibits autosomal recessive inheritance , which means that both parents must be carriers to have a 25% chance to have a child with the condition. (jewishgenetics.org)
Frequency1
- Basic demographic information for patients with harmful algal bloom-associated ED visits was summarized by frequency and percentage. (cdc.gov)
Syndromic2
- Syndromic surveillance data are useful for studying the extent of harmful algal bloom-associated illness. (cdc.gov)
- To explore the utility of syndromic surveillance data for studying health effects from harmful algal bloom exposures, CDC queried emergency department (ED) visit data from the National Syndromic Surveillance Program (NSSP) for harmful algal bloom exposure-associated administrative discharge diagnosis codes and chief complaint text terms related to harmful algal bloom exposure ( 6 ). (cdc.gov)
Abnormalities2
- and defects in RECQ4 are associated with Rothmund-Thompson syndrome, which displays growth retardation, skeletal abnormalities and premature ageing. (elifesciences.org)
- Abnormalities of spontaneous growth hormone (GH) secretion and subnormal responses to provocative growth hormone stimulation testing have been reported in a significant number of children with Silver-Russell syndrome. (medscape.com)
Cancer2
- People with Bloom syndrome have an increased risk of cancer. (medlineplus.gov)
- Bloom syndrome is a condition characterised by growth inhibition, light sensitivity, and high incidence of cancer in early life [ 1 ]. (biomedcentral.com)
Exposures3
- Increasing awareness so that more patients know to mention harmful algal bloom exposures and more physicians know to ask about them could improve documentation of health effects and enable further use of health records for health studies. (cdc.gov)
- The extent to which harmful algal bloom exposures cause human illness or long-term health effects is unknown. (cdc.gov)
- Improving the documentation of harmful algal bloom exposures in medical records would further benefit future health studies. (cdc.gov)
Cancers1
- Genetic changes that allow cells to divide in an uncontrolled way lead to the cancers that occur in people with Bloom syndrome. (medlineplus.gov)
Respiratory3
- As the number of blooms increases annually, the likelihood of negative health outcomes (e.g., respiratory or gastrointestinal illness) from exposure also increases ( 4 , 5 ). (cdc.gov)
- The unexpectedly large outbreak of Middle East respiratory syndrome in South Korea in 2015 was initiated by an infected traveler and amplified by several "superspreading" events. (cdc.gov)
- Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging zoonotic pathogen that causes an acute and fatal respiratory disease ( 1 ). (cdc.gov)
Immunodeficiency1
- The consultants also included the mother of a child with acquired immunodeficiency syndrome (AIDS), a legal advisor to a state education department, and several pediatricians who are experts in the field of pediatric AIDS. (cdc.gov)
Common1
- A retrospective study by Marsaud et al found digestive problems and malnutrition to be common in children with Silver-Russell syndrome. (medscape.com)
Description1
- Despite description of this syndrome in the late 19th century, there remain numerous unanswered neurobiological questions. (jneurosci.org)
Increase1
- An increase in harmful algal bloom-associated ED visits occurred during warmer months (June-October), consistent with seasonal fluctuations of blooms and recent publications ( 6, 7 ). (cdc.gov)
Type1
- Other complications of Klippel-Trenaunay syndrome can include a type of skin infection called cellulitis, swelling caused by a buildup of fluid (lymphedema), and internal bleeding from abnormal blood vessels. (nih.gov)
Patients1
- Bloom syndrome patients and mice display accelerated epigenetic aging. (bvsalud.org)
Similar1
- Chief complaint text terms are also used to categorize visits into many broad, medically similar syndromes using prebuilt algorithms. (cdc.gov)
Diseases1
- For the current analysis, a query was created that comprises main terms from the chief complaint (e.g., red tide, algae) along with discharge diagnostic codes associated with exposure to harmful algal blooms ( International Classification of Diseases, Tenth Revision, Clinical Modification [ICD-CM-10]) codes and their corresponding Systematized Nomenclature of Medicine [SNOMED]* Clinical Terms codes). (cdc.gov)
Condition1
- Klippel-Trenaunay syndrome is a condition that affects the development of blood vessels, soft tissues (such as skin and muscles), and bones. (nih.gov)
Large1
- Harmful algal and cyanobacterial blooms are large colonies of algae or cyanobacteria that can harm humans, animals, and the environment. (cdc.gov)
People3
Generally2
- Overall, we find that Bloom syndrome is associated with accelerated epigenetic aging effects in multiple tissues and more generally a strong effect on CpG methylation levels. (bvsalud.org)
- Do children with Cat Eye Syndrome generally experience a even in a relatively focused area of questions about specific decline in physical abilities as they reach adulthood? (nih.gov)